EDGAR Filing Documents for 0001104659-21-083496

Form 8-K - Current report:

SEC Accession No. 0001104659-21-083496

Filing Date

2021-06-21

Accepted

2021-06-21 16:15:28

Documents

Period of Report

2021-06-17

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2120045d1_8k.htm iXBRL	8-K	41668
2	EXHIBIT 3.1	tm2120045d1_ex3-1.htm	EX-3.1	4797
3	EXHIBIT 10.1	tm2120045d1_ex10-1.htm	EX-10.1	113347
	Complete submission text file	0001104659-21-083496.txt		365855

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA	albo-20210617.xsd	EX-101.SCH	3038
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE	albo-20210617_lab.xml	EX-101.LAB	34238
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	albo-20210617_pre.xml	EX-101.PRE	22367
7	EXTRACTED XBRL INSTANCE DOCUMENT	tm2120045d1_8k_htm.xml	XML	3687

Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109

Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774

ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)